查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1607167

基因扩增市场：按技术、按产品、按样本类型、按最终用户 - 2025-2030 年全球预测

Gene Amplification Technologies Market by Technology, Product, Sample Type, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年基因扩增市场估值为267.5亿美元，预计到2024年将达到279.1亿美元，复合年增长率为4.41%，到2030年将达到362亿美元。

基因扩增是指用于增加特定 DNA 序列拷贝数的技术，这对于分子诊断、研究和治疗应用至关重要。这些技术包括聚合酵素链锁反应(PCR)、定量 PCR (qPCR) 和次世代定序(NGS) 等技术，主要应用于医疗保健、生物技术和农业领域。基因扩增的需求在于能够准确检测和定量微量 DNA 和 RNA，从而促进早期疾病诊断、个人化医疗和先进生物技术研究。其应用范围从涉及感染疾病和遗传疾病检测的临床诊断到基因组研究和药物开发的研究场所。最终用户包括医院、研究机构、製药公司和寻求基因改良作物的农业公司。

主要市场统计
基准年[2023] 267.5亿美元
预计年份 [2024] 279.1亿美元
预测年份 [2030] 362亿美元
复合年增长率（%） 4.41%

这一市场成长主要是由基因组学和个人化医疗的进步、生物技术研究投资的增加以及大流行期间对高效诊断技术的需求不断增长所推动的。数位 PCR 等创新带来了关键的商机，它可以提供精确的定量，并将适用性扩展到癌症液态切片等新兴领域。此外，生物技术公司和研究机构之间的合作正在加速创新和产品开发。然而，先进技术的高成本、严格的监管要求以及基因操纵的伦理问题等挑战可能会阻碍市场成长。为了解决这些问题，我们必须努力透过技术进步来降低成本，并简化监管途径以加快产品核可。

创新领域包括开发更准确、更快速的扩增技术、提供强大的资料分析能力以及整合人工智慧以增强资料解释。他们还应该寻找灵活、可扩展的平台，以满足从大规模筛检到客製化诊断解决方案的各种需求。基因扩增市场充满活力，持续的研究和竞争推动成长。专注于个人化肿瘤治疗和环境永续农业基因组学等新应用的公司可能会获得显着的竞争优势。

市场动态：揭示快速发展的基因扩增市场的关键市场洞察

供需的动态交互作用正在改变基因扩增市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 先进 DNA 扩增技术的显着扩展
    • 基因组学和分子诊断领域的持续研究和开发活动
    • 慢性病个人化药物的需求不断增长
  • 市场限制因素
    • 技术日益复杂，PCR 设备高成本
  • 市场机会
    • 下一代基因扩增技术简介
    • 细胞和基因治疗的新进展
  • 市场挑战
    • 缺乏技术精湛、经验丰富的专业人员

波特五力：驾驭基因扩增市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解基因扩增市场的外部影响

外部宏观环境因素在塑造基因扩增市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解基因扩增市场的竞争状况

对基因扩增市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵基因扩增市场厂商绩效评估

FPNV定位矩阵是评估基因扩增市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製基因扩增市场的成功之路

基因扩增市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 先进 DNA 扩增技术的显着扩展
      • 基因组学和分子诊断领域的持续研究和开发活动
      • 慢性病个人化药物需求不断成长
    • 抑制因素
      • PCR设备技术复杂、高成本
    • 机会
      • 下一代基因扩增技术简介
      • 细胞和基因治疗的新进展
    • 任务
      • 缺乏技术精湛、经验丰富的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章基因扩增市场：依技术分类

  • 恒温环型核酸扩增
  • 基于核酸序列的扩增
  • 基于 PCR 的扩增
  • 反转录
  • 滚环放大

第七章基因扩增市场：副产品

  • 设备与设备
  • 试剂/耗材
  • 软体和服务

第八章依样本类型分類的基因扩增市场

  • 血
  • 细胞株
  • 环境
  • 病原
  • 组织

第九章基因扩增市场：依最终用户分类

  • 合约调查机构
  • 法医学研究所
  • 医院和诊断中心
  • 製药公司
  • 调查机构

第十章 北美和南美基因扩增市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区基因扩增市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲基因扩增市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 4basebio AG
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Ambion Inc.
  • Bayer Pharmaceutics AG
  • Becton Dickinson and Co.
  • Bio-Rad Laboratories
  • bioMerieux SA
  • Cepheid
  • Danaher Corporation
  • Digene Corporation
  • F. Hoffmann-La Roche Ltd.
  • Genentech, Inc.
  • Illumina Inc.
  • LGC Group
  • Menarini Silicon Biosystems SpA
  • Merck KGaA
  • MyBioSource, Inc.
  • Nanjing Vazyme Biotech Co.,Ltd.
  • New England Biolabs, Inc.
  • PerkinElmer Inc.
  • Promega Corporation
  • Qiagen NV
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-FF012EDC38AB

The Gene Amplification Technologies Market was valued at USD 26.75 billion in 2023, expected to reach USD 27.91 billion in 2024, and is projected to grow at a CAGR of 4.41%, to USD 36.20 billion by 2030.

Gene amplification technologies refer to techniques used to increase the number of copies of a specific DNA sequence, essential for applications in molecular diagnostics, research, and therapeutics. These technologies encompass methods like polymerase chain reaction (PCR), quantitative PCR (qPCR), and next-generation sequencing (NGS), primarily serving the healthcare, biotechnology, and agriculture sectors. The necessity of gene amplification lies in its ability to accurately detect and quantify minute amounts of DNA or RNA, facilitating early disease diagnosis, personalized medicine, and advanced biotechnological research. Applications are extensive, ranging from clinical diagnostics, which involves detecting infectious diseases and genetic disorders, to research settings for genomic studies and drug development. End-users include hospitals, research institutions, pharmaceutical companies, and agricultural firms seeking crop genetic improvement.

KEY MARKET STATISTICS
Base Year [2023] USD 26.75 billion
Estimated Year [2024] USD 27.91 billion
Forecast Year [2030] USD 36.20 billion
CAGR (%) 4.41%

Growth in this market is primarily driven by advances in genomics and personalized medicine, increased investment in biotechnology research, and rising demand for efficient diagnostic techniques during pandemics. Key opportunities arise from technological innovations like digital PCR, which offers precise quantification, expanding the application potential to emerging fields like cancer liquid biopsies. Additionally, collaborations between biotechnology firms and research institutions can accelerate innovation and product development. However, challenges such as high costs of advanced technologies, stringent regulatory requirements, and ethical concerns regarding genetic manipulation may hinder market growth. Addressing these involves efforts to reduce costs through technological advances and streamline regulatory pathways for faster product approvals.

Innovation areas include developing more precise and rapid amplification technologies that offer robust data analysis capabilities and integrating artificial intelligence to enhance data interpretation. Businesses should also explore flexible and scalable platforms that cater to various needs, from large-scale screenings to bespoke diagnostic solutions. The gene amplification market is dynamic, with continuous research and competition driving growth. Companies opting to focus on emerging applications like personalized oncology treatments or environmentally sustainable agrigenomics are likely to achieve significant competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Amplification Technologies Market

The Gene Amplification Technologies Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Significant expansion of advanced DNA multiplication technologies
    • Ongoing R&D activities for genomics and molecular diagnostics arena
    • Growing need for the personalized medicines for chronic conditions
  • Market Restraints
    • Technology complications and high cost of PCR instruments
  • Market Opportunities
    • Introduction of next-generation technologies for gene amplification
    • Emerging developments in cell and gene therapies
  • Market Challenges
    • Lack of skilled and experienced subject experts

Porter's Five Forces: A Strategic Tool for Navigating the Gene Amplification Technologies Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Amplification Technologies Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Amplification Technologies Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Amplification Technologies Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Amplification Technologies Market

A detailed market share analysis in the Gene Amplification Technologies Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Amplification Technologies Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Amplification Technologies Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Amplification Technologies Market

A strategic analysis of the Gene Amplification Technologies Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Amplification Technologies Market, highlighting leading vendors and their innovative profiles. These include 4basebio AG, Abbott Laboratories, Agilent Technologies, Inc., Ambion Inc., Bayer Pharmaceutics AG, Becton Dickinson and Co., Bio-Rad Laboratories, bioMerieux SA, Cepheid, Danaher Corporation, Digene Corporation, F. Hoffmann-La Roche Ltd., Genentech, Inc., Illumina Inc., LGC Group, Menarini Silicon Biosystems SpA, Merck KGaA, MyBioSource, Inc., Nanjing Vazyme Biotech Co.,Ltd., New England Biolabs, Inc., PerkinElmer Inc., Promega Corporation, Qiagen N.V., Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Gene Amplification Technologies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Loop-mediated Isothermal Amplification, Nucleic Acid Sequence Based Amplification, PCR-based Amplification, Reverse Transcription, and Rolling Circle Amplification.
  • Based on Product, market is studied across Instruments & Equipment, Reagents & Consumables, and Software & Services.
  • Based on Sample Type, market is studied across Blood, Cell Lines, Environmental, Pathogen, and Tissue.
  • Based on End-User, market is studied across Contract Research Organizations, Forensic Labs, Hospitals & Diagnostic Centers, Pharmaceutical Companies, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant expansion of advanced DNA multiplication technologies
      • 5.1.1.2. Ongoing R&D activities for genomics and molecular diagnostics arena
      • 5.1.1.3. Growing need for the personalized medicines for chronic conditions
    • 5.1.2. Restraints
      • 5.1.2.1. Technology complications and high cost of PCR instruments
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of next-generation technologies for gene amplification
      • 5.1.3.2. Emerging developments in cell and gene therapies
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled and experienced subject experts
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gene Amplification Technologies Market, by Technology

  • 6.1. Introduction
  • 6.2. Loop-mediated Isothermal Amplification
  • 6.3. Nucleic Acid Sequence Based Amplification
  • 6.4. PCR-based Amplification
  • 6.5. Reverse Transcription
  • 6.6. Rolling Circle Amplification

7. Gene Amplification Technologies Market, by Product

  • 7.1. Introduction
  • 7.2. Instruments & Equipment
  • 7.3. Reagents & Consumables
  • 7.4. Software & Services

8. Gene Amplification Technologies Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood
  • 8.3. Cell Lines
  • 8.4. Environmental
  • 8.5. Pathogen
  • 8.6. Tissue

9. Gene Amplification Technologies Market, by End-User

  • 9.1. Introduction
  • 9.2. Contract Research Organizations
  • 9.3. Forensic Labs
  • 9.4. Hospitals & Diagnostic Centers
  • 9.5. Pharmaceutical Companies
  • 9.6. Research Institutes

10. Americas Gene Amplification Technologies Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Gene Amplification Technologies Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Gene Amplification Technologies Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 4basebio AG
  • 2. Abbott Laboratories
  • 3. Agilent Technologies, Inc.
  • 4. Ambion Inc.
  • 5. Bayer Pharmaceutics AG
  • 6. Becton Dickinson and Co.
  • 7. Bio-Rad Laboratories
  • 8. bioMerieux SA
  • 9. Cepheid
  • 10. Danaher Corporation
  • 11. Digene Corporation
  • 12. F. Hoffmann-La Roche Ltd.
  • 13. Genentech, Inc.
  • 14. Illumina Inc.
  • 15. LGC Group
  • 16. Menarini Silicon Biosystems SpA
  • 17. Merck KGaA
  • 18. MyBioSource, Inc.
  • 19. Nanjing Vazyme Biotech Co.,Ltd.
  • 20. New England Biolabs, Inc.
  • 21. PerkinElmer Inc.
  • 22. Promega Corporation
  • 23. Qiagen N.V.
  • 24. Takara Bio Inc.
  • 25. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GENE AMPLIFICATION TECHNOLOGIES MARKET RESEARCH PROCESS
  • FIGURE 2. GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. GENE AMPLIFICATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. GENE AMPLIFICATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE AMPLIFICATION TECHNOLOGIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE AMPLIFICATION TECHNOLOGIES MARKET DYNAMICS
  • TABLE 7. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY LOOP-MEDIATED ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY NUCLEIC ACID SEQUENCE BASED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PCR-BASED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REVERSE TRANSCRIPTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ROLLING CIRCLE AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY INSTRUMENTS & EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CELL LINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY ENVIRONMENTAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PATHOGEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TISSUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM GENE AMPLIFICATION TECHNOLOGIES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. GENE AMPLIFICATION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. GENE AMPLIFICATION TECHNOLOGIES MARKET, FPNV POSITIONING MATRIX, 2023